{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:17:27Z","timestamp":1761311847932,"version":"3.41.2"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Adrenal insufficiency (AI) is a life-threatening disorder, with increased morbidity and mortality, especially in case of an acute illness that can increase the requirement of cortisol. A novel infectious disease, termed Coronavirus Disease 2019 (COVID-19), appeared in 2020. Therefore, AI patients are experiencing a novel challenge: the risk of infection. In our experience, a prompt contact to the Endocrine center (with a telemedicine consultation) and a full awareness of diseases (cortisol deficiency, COVID-19 and the self-management of an adrenal crisis) are important to motivate patients. Vaccine is an effective treatment to prevent hospitalization and aggressive course of COVID-19. Some patients manifest challenges due to inequitable access and vaccine hesitancy, resulting in a delay in the acceptance of vaccines despite the availability of vaccination services. Therefore, an effort of all physicians must be conducted in order to advise patients with AI. In this short review, we try to answer some frequently asked questions regarding the management of patients with AI.<\/jats:p>","DOI":"10.3389\/fendo.2021.805647","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T07:47:15Z","timestamp":1640332035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19"],"prefix":"10.3389","volume":"12","author":[{"given":"Chiara","family":"Sabbadin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Betterle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus\u2013Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed Asymptomatic Carrier Transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40267-021-00869-4","article-title":"COVID-19: State of the Vaccination","volume":"15","author":"Fenton","year":"2021","journal-title":"Drugs Ther Perspect Ration Drug Sel Use"},{"key":"B5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/vaccines9090989","article-title":"Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3","volume":"9","author":"Fan","year":"2021","journal-title":"Vaccines"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2018-0824","article-title":"Central Adrenal Insufficiency: Open Issues Regarding Diagnosis and Glucocorticoid Treatment","volume":"57","author":"Ceccato","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01266-w","article-title":"COVID-19 Infection and Glucocorticoids: Update From the Italian Society of Endocrinology Expert Opinion on Steroid Replacement in Adrenal Insufficiency","volume":"43","author":"Isidori","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0076","article-title":"Premature Mortality in Patients With Addison\u2019s Disease: A Population-Based Study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased Death Risk and Altered Cancer Incidence Pattern in Patients With Isolated or Combined Autoimmune Primary Adrenocortical Insufficiency","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0550","article-title":"Normal Overall Mortality Rate in Addison\u2019s Disease, But Young Patients Are at Risk of Premature Death","volume":"160","author":"Erichsen","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9835-4","article-title":"Therapy of Adrenal Insufficiency: An Update","volume":"43","author":"Falorni","year":"2013","journal-title":"Endocrine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0969","article-title":"Primary Adrenal Insufficiency Is Associated With Impaired Natural Killer Cell Function: A Potential Link to Increased Mortality","volume":"176","author":"Bancos","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz006","article-title":"Increased Infection Risk in Addison\u2019s Disease and Congenital Adrenal Hyperplasia","volume":"105","author":"Tresoldi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of Once-Daily, Modified-Release Hydrocortisone Versus Standard Glucocorticoid Therapy on Metabolism and Innate Immunity in Patients With Adrenal Insufficiency (DREAM): A Single-Blind, Randomised Controlled Trial","volume":"6","author":"Isidori","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0657","article-title":"Mortality in Patients With Diabetes Mellitus and Addison\u2019s Disease: A Nationwide, Matched, Observational Cohort Study","volume":"176","author":"Chantzichristos","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01146-y","article-title":"Towards the Tailoring of Glucocorticoid Replacement in Adrenal Insufficiency: The Italian Society of Endocrinology Expert Opinion","volume":"43","author":"Isidori","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0361","article-title":"Endocrinology in the Time of COVID-19: Management of Adrenal Insufficiency","volume":"183","author":"Arlt","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1055\/a-1217-7208","article-title":"Therapeutic Patient Education for Adrenal Insufficiency Under COVID-19 Pandemic Conditions","volume":"129","author":"Kienitz","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01422-2","article-title":"Impact of COVID-19 Pandemic on Psychophysical Stress in Patients With Adrenal Insufficiency: The CORTI-COVID Study","volume":"44","author":"Martino","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa793","article-title":"Adrenal Insufficiency at the Time of COVID-19: A Retrospective Study in Patients Referring to a Tertiary Center","volume":"106","author":"Carosi","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01106-3","article-title":"The Direct and Indirect Impact of the COVID-19 Pandemic on the Care of Patients With Pituitary Disease: A Cross Sectional Study","volume":"24","author":"Graf","year":"2021","journal-title":"Pituitary"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab334","article-title":"The Impact of the COVID-19 Pandemic on Self-Reported Outcomes in Patients With Adrenal Insufficiency","volume":"106","author":"Li","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01585-6","article-title":"Autoimmune Polyendocrine Syndrome Type 1: An Italian Survey on 158 Patients","volume":"44","author":"Garelli","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa140","article-title":"Patients With APECED Have Increased Early Mortality Due to Endocrine Causes, Malignancies and Infections","volume":"105","author":"Borchers","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune Polyendocrine Syndromes. Ingelfinger JR, Ed","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210554","article-title":"Preexisting Autoantibodies to Type I IFNs Underlie Critical COVID-19 Pneumonia in Patients With APS-1","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/genes12020169","article-title":"Autoimmune Polyendocrinopathy\u2013Candidiasis\u2013Ectodermal Dystrophy in Two Siblings: Same Mutations But Very Different Phenotypes","volume":"12","author":"Carpino","year":"2021","journal-title":"Genes (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12162","article-title":"Consensus Statement on the Diagnosis, Treatment and Follow-Up of Patients With Primary Adrenal Insufficiency","volume":"275","author":"Husebye","year":"2014","journal-title":"J Intern Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ando.2017.12.001","article-title":"SFE\/SFEDP Adrenal Insufficiency French Consensus: Introduction and Handbook","volume":"79","author":"Reznik","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2142150.075","article-title":"Diverse Etiologies, Diagnostic Approach, and Management of Primary Adrenal Insufficiency in Pediatric Age","volume":"26","author":"Yoo","year":"2021","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01476-2","article-title":"Tele-Medicine Versus Face-to-Face Consultation in Endocrine Outpatients Clinic During COVID-19 Outbreak: A Single-Center Experience During the Lockdown Period","volume":"44","author":"Ceccato","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007720.pub3","article-title":"Corticosteroids for Pneumonia","volume":"12","author":"Stern","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30149-2","article-title":"Use of Glucocorticoids in Patients With Adrenal Insufficiency and COVID-19 Infection","volume":"8","author":"Isidori","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients With Covid-19 \u2014 Preliminary Report","volume":"384","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40618-020-01384-5","article-title":"What We Have to Know About Corticosteroids Use During Sars-Cov-2 Infection","volume":"44","author":"Ferra\u00f9","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-5-412","article-title":"Iatrogenic Cushing\u2019s Syndrome Due to Drug Interaction Between Glucocorticoids and the Ritonavir or Cobicistat Containing HIV Therapies","volume":"16","author":"Elliot","year":"2016","journal-title":"Clin Med (Northfield Il)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12039","article-title":"Inhaled Corticosteroid Use in HIV-Positive Individuals Taking Protease Inhibitors: A Review of Pharmacokinetics, Case Reports and Clinical Management","volume":"14","author":"Saberi","year":"2013","journal-title":"HIV Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s40064-015-1218-x","article-title":"Iatrogenic Cushing Syndrome and Adrenal Insufficiency During Concomitant Therapy With Ritonavir and Fluticasone","volume":"4","author":"Epperla","year":"2015","journal-title":"Springerplus"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00579.x","article-title":"Adrenal Suppression and Cushing\u2019s Syndrome Secondary to an Interaction Between Ritonavir and Fluticasone: A Review of the Literature","volume":"9","author":"Foisy","year":"2008","journal-title":"HIV Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.endinu.2017.02.006","article-title":"Adrenal Insufficiency and Exogenous Cushing\u2019s Syndrome in a Patient Receiving Inhaled Fluticasone and Ritonavir","volume":"64","author":"Zubillaga","year":"2017","journal-title":"Endocrinol Diabetes y Nutr"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2011.03.019","article-title":"The Effect of Interferon-\u03b1 on the Expression of Cytochrome P450 3A4 in Human Hepatoma Cells","volume":"253","author":"Flaman","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.1996.v24.pm0008690406","article-title":"Interferon Gamma Down-Regulates Cytochrome P450 3A Genes in Primary Cultures of Well-Differentiated Rat Hepatocytes","volume":"24","author":"Tapner","year":"1996","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2008.58","article-title":"Interferon-\u03b1 Effects on Diurnal Hypothalamic\u2013Pituitary\u2013Adrenal Axis Activity: Relationship With Proinflammatory Cytokines and Behavior","volume":"15","author":"Raison","year":"2010","journal-title":"Mol Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80034-1","article-title":"Modulation of Constitutive and Inducible Hepatic Cytochrome(s) P-450 by Interferon \u03b2 in Mice","volume":"24","author":"Carelli","year":"1996","journal-title":"J Hepatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2265.2005.02325.x","article-title":"Hypocortisolism in Survivors of Severe Acute Respiratory Syndrome (SARS)","volume":"63","author":"Leow","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0722","article-title":"Case Report: COVID-19 With Bilateral Adrenal Hemorrhage","volume":"103","author":"\u00c1lvarez-Troncoso","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab557","article-title":"Primary Adrenal Insufficiency Due to Bilateral Adrenal Infarction in COVID-19","volume":"107","author":"Machado","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0787","article-title":"Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study","volume":"103","author":"Freire Santana","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-1971-9","article-title":"Serum Cytokines and Critical Illness-Related Corticosteroid Insufficiency","volume":"36","author":"Kwon","year":"2010","journal-title":"Intensive Care Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4919-5","article-title":"Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"43","author":"Annane","year":"2017","journal-title":"Intensive Care Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1166","article-title":"Utility of Salivary Cortisol Measurements in Cushing\u2019s Syndrome and Adrenal Insufficiency","volume":"94","author":"Raff","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0352","article-title":"Endocrinology in the Time of COVID-19: Management of Cushing\u2019s Syndrome","volume":"183","author":"Newell-Price","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0404","article-title":"Low-Dose Short Synacthen Test With Salivary Cortisol in Patients With Suspected Central Adrenal Insufficiency","volume":"10","author":"Ceccato","year":"2021","journal-title":"Endocr Connect"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14286","article-title":"Long-Acting Porcine ACTH Stimulated Salivary Cortisol in the Diagnosis of Adrenal Insufficiency","volume":"93","author":"George","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/vaccines9080815","article-title":"Vaccinations and Autoimmune Diseases","volume":"9","author":"Olivieri","year":"2021","journal-title":"Vaccines"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102506","article-title":"Autoinflammatory and Autoimmune Conditions at the Crossroad of COVID-19","volume":"114","author":"Rodr\u00edguez","year":"2020","journal-title":"J Autoimmun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential Antigenic Cross-Reactivity Between SARS-CoV-2 and Human Tissue With a Possible Link to an Increase in Autoimmune Diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06062-x","article-title":"High Risk of Thrombosis in Patients With Severe SARS-CoV-2 Infection: A Multicenter Prospective Cohort Study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102592","article-title":"The JANUS of Chronic Inflammatory and Autoimmune Diseases Onset During COVID-19 \u2013 A Systematic Review of the Literature","volume":"117","author":"Novelli","year":"2021","journal-title":"J Autoimmun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16774","article-title":"Cutaneous Manifestations of SARS-CoV-2 Infection: A Clinical Update","volume":"34","author":"Gisondi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2021.06.025","article-title":"Primary Adrenal Insufficiency Associated With Oxford-AstraZeneca ChAdOx1 Ncov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)","volume":"91","author":"Varona","year":"2021","journal-title":"Eur J Intern Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01130-x","article-title":"Glucocorticoid Use in Patients With Adrenal Insufficiency Following Administration of the COVID-19 Vaccine: A Pituitary Society Statement","volume":"24","author":"Katznelson","year":"2021","journal-title":"Pituitary"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.805647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T07:47:18Z","timestamp":1640332038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.805647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":65,"alternative-id":["10.3389\/fendo.2021.805647"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.805647","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2021,12,24]]},"article-number":"805647"}}